Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sorting nexin 9 (SNX9) functions in a complex with the GTPase dynamin-2 at clathrin-coated pits, where it provokes fission of vesicles to complete endocytosis. Here the SNX9.dynamin-2 complex binds to clathrin and adapter protein complex 2 (AP-2) that line these pits, and this occurs through interactions of the low complexity domain (LC4) of SNX9 with AP-2. Intriguingly, localization of the SNX9.dynamin-2 complex to clathrin-coated pits is blocked by interactions with the abundant glycolytic enzyme
aldolase
, which also binds to the LC4 domain of SNX9. The crystal structure of the LC4 motif of human SNX9 in complex with
aldolase
explains the biochemistry and biology of this interaction, where SNX9 binds near the active site of
aldolase
via residues 165-171 that are also required for the interactions of SNX9 with AP-2. Accordingly, SNX9 binding to
aldolase
is structurally precluded by the binding of substrate to the active site. Interactions of SNX9 with
aldolase
are far more extensive and differ from those of the actin-nucleating factor
WASP
with
aldolase
, indicating considerable plasticity in mechanisms that direct the functions of the
aldolase
as a scaffold protein.
...
PMID:Mechanism of aldolase control of sorting nexin 9 function in endocytosis. 2012 22